The table below shows 10x Genomics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$150.84M
$149.00M
$172.91M
$154.88M
$151.65M
$153.10M
Cost of revenue
$44.66M
$48.70M
$47.82M
$49.44M
$45.26M
$48.88M
Gross profit
$106.18M
$100.31M
$125.08M
$105.44M
$106.39M
$104.22M
R&D
-
-
-
-
-
-
TXG annual revenue (10-K history)
10x Genomics, Inc. reported annual revenue of $642.82M for fiscal year 2025. That is up 5.2% from $610.78M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $71.08M (FY 2017) to $642.82M. Figures come from the company's audited annual reports as filed with the SEC.
